doi.org/10.1016/j.phrs.2021.105579

Properties of FDA-approved small molecule phosphatidylinositol 3-kinase inhibitors prescribed for the treatment of malignancies

Robert Roskoski
56
Pharmacological Research10.50
Volume: 168, Pages: 105579 - 105579
Published: Mar 26, 2021
Paper Fields
Paper Details
Title
Properties of FDA-approved small molecule phosphatidylinositol 3-kinase inhibitors prescribed for the treatment of malignancies
DOI
doi.org/10.1016/j.phrs.2021.105579
Published Date
Mar 26, 2021
Journal
Pharmacological Research
Volume
168
Pages
105579 - 105579
© 2025 Pluto Labs All rights reserved.